Order Article Reprints

Jacobs TG, de Hoop-Sommen MA, Nieuwenstein T, van der Heijden JEM, de Wildt SN, Burger DM, Colbers A, Freriksen JJM. Lamivudine and Emtricitabine Dosing Proposal for Children with HIV and Chronic Kidney Disease, Supported by Physiologically Based Pharmacokinetic Modelling. Pharmaceutics. 2023; 15(5):1424. https://doi.org/10.3390/pharmaceutics15051424

Jacobs, Tom G., Marika A. de Hoop-Sommen, Thomas Nieuwenstein, Joyce E. M. van der Heijden, Saskia N. de Wildt, David M. Burger, Angela Colbers, and Jolien J. M. Freriksen. 2023. "Lamivudine and Emtricitabine Dosing Proposal for Children with HIV and Chronic Kidney Disease, Supported by Physiologically Based Pharmacokinetic Modelling" Pharmaceutics 15, no. 5: 1424. https://doi.org/10.3390/pharmaceutics15051424

Jacobs, T. G., de Hoop-Sommen, M. A., Nieuwenstein, T., van der Heijden, J. E. M., de Wildt, S. N., Burger, D. M., Colbers, A., & Freriksen, J. J. M. (2023). Lamivudine and Emtricitabine Dosing Proposal for Children with HIV and Chronic Kidney Disease, Supported by Physiologically Based Pharmacokinetic Modelling. Pharmaceutics, 15(5), 1424. https://doi.org/10.3390/pharmaceutics15051424